Featured Research

from universities, journals, and other organizations

How invariant natural killers keep tuberculosis in check

Date:
January 3, 2014
Source:
Public Library of Science
Summary:
Mycobacterium tuberculosis is a major cause of death worldwide, and a formidable foe. Most healthy people can defend themselves against tuberculosis, but they need all parts of their immune system to work together. A new study reveals how a special class of immune cells called "invariant natural killer T cells" make their contribution to this concerted effort.

This shows macrophages infected with Mycobacterium tuberculosis.
Credit: Alissa Rothchild, CC-BY

Mycobacterium tuberculosis is a major cause of death worldwide, and a formidable foe. Most healthy people can defend themselves against tuberculosis, but they need all parts of their immune system to work together. A study published on January 2nd in PLOS Pathogens reveals how a special class of immune cells called "invariant natural killer T cells" make their contribution to this concerted effort.

"We were interested in identifying the mechanisms that different types of T cells use to control Mycobacterium tuberculosis infection," says Samuel Behar, from the University of Massachusetts Medical School, US, the senior author of the new study.

He and his colleagues had previously shown that when invariant natural killer T (iNKT) cells encounter infected macrophages--the human target cells of Mycobacterium tuberculosis, or Mtb--the iNKT cells somehow prevented Mtb from growing and multiplying inside the macrophages.

In this study, the scientists focused on how the iNKT cells achieved this. Using a number of cell culture systems and experiments in mice to dissect the interaction, they found that when iNKT cells are confronted with Mtb-infected macrophages, they respond in two different ways. One is that they produce and release interferon gamma, a broad-spectrum immune system activator. But when the scientists blocked interferon gamma action, they found that the iNKT cells could still inhibit Mtb growth in the macrophages.

After testing a few more known mediators of iNKT cell function and finding that they were dispensable as well, the scientists discovered that Mtb control depends on production and release by the iNKT cells of a soluble immune system factor called GM-CSF. When they blocked GM-CSF, they found that iNKT cells could no longer restrict mycobacterial growth. And when they exposed isolated Mtb-infected macrophages to GM-CSF, it turned out that this factor alone was sufficient to inhibit Mtb growth.

These results are exciting in the context of previous findings that mice in which the GM-CSF gene had been deleted were more susceptible to Mtb infection, because they link iNKT cells and GM-CSF and identify a novel pathway of Mtb control by the immune system.

Overall, the scientists say "Understanding how iNKT cells contribute to the control and elimination of Mtb in general and finding that GM-CSF has an essential function could lead to novel therapeutic approaches that strengthen their activity and boost the overall immune response during infection."


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. Alissa C. Rothchild, Pushpa Jayaraman, Clαudio Nunes-Alves, Samuel M. Behar. iNKT Cell Production of GM-CSF Controls Mycobacterium tuberculosis. PLoS Pathogens, 2014; 10 (1): e1003805 DOI: 10.1371/journal.ppat.1003805

Cite This Page:

Public Library of Science. "How invariant natural killers keep tuberculosis in check." ScienceDaily. ScienceDaily, 3 January 2014. <www.sciencedaily.com/releases/2014/01/140103085626.htm>.
Public Library of Science. (2014, January 3). How invariant natural killers keep tuberculosis in check. ScienceDaily. Retrieved April 16, 2014 from www.sciencedaily.com/releases/2014/01/140103085626.htm
Public Library of Science. "How invariant natural killers keep tuberculosis in check." ScienceDaily. www.sciencedaily.com/releases/2014/01/140103085626.htm (accessed April 16, 2014).

Share This



More Health & Medicine News

Wednesday, April 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Outbreak Now Linked To 121 Deaths

Ebola Outbreak Now Linked To 121 Deaths

Newsy (Apr. 15, 2014) — The ebola virus outbreak in West Africa is now linked to 121 deaths. Health officials fear the virus will continue to spread in urban areas. Video provided by Newsy
Powered by NewsLook.com
Cognitive Function: Is It All Downhill From Age 24?

Cognitive Function: Is It All Downhill From Age 24?

Newsy (Apr. 15, 2014) — A new study out of Canada says cognitive motor performance begins deteriorating around age 24. Video provided by Newsy
Powered by NewsLook.com
How Mt. Everest Helped Scientists Research Diabetes

How Mt. Everest Helped Scientists Research Diabetes

Newsy (Apr. 15, 2014) — British researchers were able to use Mount Everest's low altitudes to study insulin resistance. They hope to find ways to treat diabetes. Video provided by Newsy
Powered by NewsLook.com
Carpenter's Injury Leads To Hundreds Of 3-D-Printed Hands

Carpenter's Injury Leads To Hundreds Of 3-D-Printed Hands

Newsy (Apr. 14, 2014) — Richard van As lost all fingers on his right hand in a woodworking accident. Now, he's used the incident to create a prosthetic to help hundreds. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins